Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,620 | -2,286 | -27,582 | -20,915 | -16,716 |
| Depreciation Amortization | 684 | 345 | 3,791 | 3,428 | 2,502 |
| Accounts receivable | 76 | -2,314 | -1,032 | -4,075 | -1,587 |
| Other Working Capital | -5,988 | -4,611 | 9,801 | 9,334 | 9,660 |
| Other Operating Activity | -337 | 3,037 | 4,737 | 7,030 | 2,823 |
| Operating Cash Flow | $-13,185 | $-5,829 | $-10,285 | $-5,198 | $-3,318 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 58,271 | 20,359 | 15,359 |
| PPE Investments | -357 | -229 | -1,406 | -958 | -614 |
| Purchase Of Investment | -16,000 | -16,000 | -37,835 | -37,835 | -37,835 |
| Other Investing Activity | 457 | -28 | -109 | -81 | -54 |
| Investing Cash Flow | $-15,900 | $-16,257 | $18,921 | $-18,515 | $-23,144 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -34,122 | -30,076 | N/A |
| Common Stock Issued | 2,643 | N/A | 46,200 | 46,200 | 46,200 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -4,086 |
| Financing Cash Flow | $2,643 | $N/A | $12,078 | $16,124 | $42,114 |
| Exchange Rate Effect | -51 | -11 | 6 | -34 | -35 |
| Beginning Cash Position | 38,985 | 38,985 | 18,265 | 18,265 | 18,265 |
| End Cash Position | 12,492 | 16,888 | 38,985 | 10,642 | 33,882 |
| Net Cash Flow | $-26,493 | $-22,097 | $20,720 | $-7,623 | $15,617 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,185 | -5,829 | -10,285 | -5,198 | -3,318 |
| Capital Expenditure | -357 | -229 | -1,459 | -1,011 | -667 |
| Free Cash Flow | -13,542 | -6,058 | -11,744 | -6,209 | -3,985 |